89 related articles for article (PubMed ID: 7872726)
1. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
Lindahl B; Willén R
Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
Lindahl B; Willén R
Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
[TBL] [Abstract][Full Text] [Related]
3. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
Lindahl B; Willén R
Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
[TBL] [Abstract][Full Text] [Related]
4. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
Lindahl B; Alm P; Fernö M; Norgren A
Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
[TBL] [Abstract][Full Text] [Related]
5. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Vereide AB; Kaino T; Sager G; Ørbo A;
Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
8. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
9. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
Lindahl B; Willén R
Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
[TBL] [Abstract][Full Text] [Related]
10. Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases.
Bobrowska K; Pietrzak B; Jabiry-Zieniewicz Z; Cyganek A; Kaminski P; Wielgos M; Durlik M
Transplant Proc; 2007 Nov; 39(9):2756-8. PubMed ID: 18021979
[TBL] [Abstract][Full Text] [Related]
11. Endometrial abnormalities in infertile women.
Kurabayashi T; Kase H; Suzuki M; Sugaya S; Fujita K; Tanaka K
J Reprod Med; 2003 Jun; 48(6):455-9. PubMed ID: 12856518
[TBL] [Abstract][Full Text] [Related]
12. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
13. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous endometrial hyperplasia. The prognostic significance of steroid receptor concentration. A two year follow-up of patients treated with abrasio only.
Lindahl B; Fernö M; Norgren A; Willen R
Anticancer Res; 1991; 11(5):1875-7. PubMed ID: 1768058
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation.
Yasuda M; Matsui N; Kajiwara H; Osamura RY; Miyamoto T; Murakami M; Shinozuka T; Itoh J
Pathol Int; 2004 Jun; 54(6):451-6. PubMed ID: 15144406
[TBL] [Abstract][Full Text] [Related]
16. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
Lindahl B; Willén R
Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
19. [Atypical endometrial hyperplasia. Prognosis and course].
Jensen HH; Hussain SF; Pedersen PH; Andreasson B
Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
[TBL] [Abstract][Full Text] [Related]
20. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
Pérez-Medina T; Bajo J; Folgueira G; Haya J; Ortega P
Gynecol Oncol; 1999 May; 73(2):299-304. PubMed ID: 10329050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
